Eliot M. Lurier

2022

In 2022, Eliot M. Lurier earned a total compensation of $221.7K as Interim Chief Financial Officer at Tenax Therapeutics, a 756% increase compared to previous year.

Compensation breakdown

Other$221,700
Total$221,700

Lurier received $221.7K in other compensation, accounting for 100% of the total pay in 2022.

Rankings

In 2022, Eliot M. Lurier's compensation ranked 5,175th out of 5,538 executives tracked by ExecPay. In other words, Lurier earned more than 6.6% of executives.

ClassificationRankingPercentile
All
5,175
out of 5,538
7th
Division
Manufacturing
2,829
out of 3,000
6th
Major group
Chemicals And Allied Products
1,303
out of 1,350
4th
Industry group
Drugs
1,216
out of 1,253
3rd
Industry
Pharmaceutical Preparations
878
out of 907
3rd
Source: SEC filing on April 28, 2023.

Lurier's colleagues

We found two more compensation records of executives who worked with Eliot M. Lurier at Tenax Therapeutics in 2022.

2022

Christopher Giordano

Tenax Therapeutics

Chief Executive Officer

2022

Stuart Rich

Tenax Therapeutics

Chief Medical Officer

News

You may also like